• About us
• Contact

Advertisement

Organisation › Details

Macroceutics Inc.

Macroceutics is a privately-owned biotechnology company based in central New Jersey. Macroceutics has made multiple large DNA-Encoded Libraries (DELs) with extremely robust chemistry processes and established a fully-functional DEL target-screening platform. The available screening collection encompasses hundreds of highly diverse scaffolds, and the compounds exhibit very drug-like physical properties. *

 

	Start	2019-08-23 existent
	End	2019-08-23 acquired
	Group	HotSpot Therapeutics (Group)
	Today	HotSpot Therapeutics (Group)
	Successor	HotSpot Therapeutics (Group)
	Industry	DNA-Encoded chemical libraries (DELs)
	Industry 2	SpotFinder™ technology
	Region	Monmouth Junction, NJ
	Country	United States (USA)
	Street	9 Deer Park Drive Suite K-1
	City	08852 Monmouth Junction, NJ
	Tel	+1-732-823-1633
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for »About Section«: Arvinas, LLC. (11/21/17). "Press Release: Arvinas and Macroceutics Establish DEL Screening Collaboration on Undruggable Targets". New Haven, CT & Monmouth Junction, NJ.
		Record changed: 2023-07-10

Advertisement

More documents for HotSpot Therapeutics (Group)

• [1] HotSpot Therapeutics, Inc.. (11/29/21). "Press Release: HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic". Boston, MA....
• [2] HotSpot Therapeutics, Inc.. (5/21/20). "Press Release: HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines". Boston, MA....
• [3] HotSpot Therapeutics, Inc.. (8/23/19). "Press Release: HotSpot Therapeutics Announces Acquisition of Macroceutics, Inc.". Boston, MA....
• [4] HotSpot Therapeutics, Inc.. (10/30/18). "Press Release: HotSpot Therapeutics Expands Board of Directors and Management Team". Cambridge, MA....
• [5] HotSpot Therapeutics, Inc.. (7/17/18). "Press Release: HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discvovery". Cambridge, MA....
• [6] Arvinas, LLC. (11/21/17). "Press Release: Arvinas and Macroceutics Establish DEL Screening Collaboration on Undruggable Targets". New Haven, CT & Monmouth Junction, NJ....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.